NR4A1 and neoplasm: Remarkably, Nr4a1−/− mice treated with αPD‐1 exhibited a pronounced reduction in tumor burden and extended OS, accompanied by significantly lower Ki67 expression in lung tumors compared to control mice (Figure 6b–e; Figure S10a, Supporting Information).